Medication – Kepplah Fri, 14 Jan 2022 14:10:15 +0000 en-US hourly 1 Medication – Kepplah 32 32 Doctors express concern over unwarranted medication and hospitalization during Covid Fri, 14 Jan 2022 14:10:15 +0000

New Delhi, Jan 14 (IANS): A group of around 35 doctors from across the country have written an open letter to the union’s Department of Health regarding unwarranted testing, medication and hospitalization during the ongoing Covid pandemic and called for urgent intervention for a response evidence-based to the current wave.

“While there is still a great deal of uncertainty amid the outbreak of this new disease, there is now substantial high quality scientific literature that provides unequivocal guidance on the clinical management of Covid-19. Despite the weight of this evidence and the overwhelming number of delta wave deaths, we find that the mistakes of the 2021 response are repeated in 2022,” the open letter reads.

Doctors identified three main issues of wrongful medications, wrongful tests and wrongful hospitalizations.

The letter says the vast majority of patients with Covid-19, with asymptomatic and mild symptoms, will require little or no medication. “Most of the prescriptions we have looked at over the past two weeks include multiple Covid-19 ‘kits’ and cocktails. The prescription of combination vitamins, azithromycin, doxycycline, hydroxychloroquine, favipiravir and ivermectin to treat Covid-19 is an irrational practice. Such gratuitous use of drugs is not without danger, as the Delta wave has shown. Outbreaks of opportunistic fungal infections like mucormycosis in India and aspergillosis in Brazil have been attributed to the widespread misuse of inappropriate medications,” the letter states.

Speaking to IANS, Dr Anant Bhan, Yenepoya (considered a university), Mangaluru, one of the signatories said that with almost two years of fighting the pandemic behind us, it is extremely important to ensure that evidence-based medical and policy decisions are made. Our letter calls on all relevant stakeholders to focus on public health measures, including vaccination, and to ensure that inappropriate medications and diagnoses are discouraged.

In the open letter, they called on central and state health authorities to end these “unwarranted” practices and promote evidence-based medicine. He suggested updating the June 2021 DGHS evidence-based guidelines. Through public education and professional training, discourage the use of drugs that have no supporting evidence for the treatment of Covid-19, doctors said.

Doctors also suggested discouraging the use of unwarranted diagnoses, especially for asymptomatic and mild cases, where none are required except for antigen or PCR confirmation tests and publishing guidelines in local languages. Stop any state-sponsored promotion or distribution of drugs, cocktails, alternative therapies or potions that are not scientifically proven therapies, the letter suggests.

Provide all healthcare workers with adequate N95 masks and eye protection. Continue to accelerate vaccination, building on current successes, says the letter signed by a few doctors of Indian origin at Harvard and Johns Hopkins universities in the United States.

El Paso Walmart, Sam’s Club Pharmacies Dispensing Authorized COVID-19 Antiviral Drugs Wed, 12 Jan 2022 19:06:17 +0000


(AP Photo/Alan Diaz, File)

EL PASO, Texas (KTSM) — On Wednesday morning, Walmart and Sam’s Club officials announced that their pharmacies have begun distributing licensed COVID-19 antiviral drugs Paxlovid and Molnupiravir in El Paso through Federal Retail Pharmacy Therapeutics. United States program.

Some Walmart and Sam’s Club pharmacies have received limited supplies of COVID-19 antiviral drugs. The drug is only available with a prescription from a healthcare professional.

Since COVID-19 antiviral drugs are prescribed for people with COVID-19, they are only available at Walmart and Sam’s Club via curbside pickup or through drive-thru drug store windows.

Walmart has worked closely with federal and state health departments to select locations where states have determined treatment is most needed. Although the initial supply of treatment is limited, Walmart and Sam’s Club pharmacies are ready to help expand access to treatment nationwide.

We are committed to working with our state and federal partners to provide access to new treatment options such as licensed COVID-19 antiviral drugs, as they become available.

This provides customers with the ability to recover at home and helps reduce the burden on our hospitals and communities.

As we have done since the beginning of the pandemic, we are proud to support our communities on a daily basis
essentials, healthy food, vaccines, medicines and other healthcare needs as we all work together to tackle the pandemic.

kevin host, senior vice president of pharmacy

Customers and healthcare providers can go online and use the store locator to find the nearest store or club that sells that medicine to submit the e-prescription.

For local news and breaking news, sports, weather alerts, videos and more, download the FREE KTSM 9 News app from Apple App Store or the Google Play Store.

Self-medication is not a panacea: Docs | Hyderabad News Mon, 10 Jan 2022 22:26:00 +0000 Hyderabad: In the midst of the third wave of the pandemic, many are turning to self-medication again. People show up to the doctor’s office after taking all of the known medications like remdesivir, hydroxychloroquine (HCQ), molnupiravir among others.
On the one hand, this self-medication suppresses the symptoms, on the other hand, it leaves very few options for the doctor to treat the patient, according to health experts.
“A few days ago I ran into a patient who had taken all the antibiotics he knew for fever and sore throat and came to me after five days telling me he didn’t feel not better. As he had taken everything, I told him that I was prescribing paracetamol which is the only medicine he did not take, ”said Dr Rahul Agarwal, senior consultant at Care Hospitals. Dr Agarwal said these patients have been coming to hospitals almost every other day lately.
Few understand that these drugs can be dangerous chemical formulations that have been unnecessarily introduced into their body. The other problem with self-medication is that it often leads to over-medication when there is no indication and in the long run leads to resistance.
The fact that doctors have very few drugs to prescribe to treat the virus makes matters worse. “In the past 50 years, no new class of antibiotics has been introduced. Everything that had been there was only improved. Therefore, with prolonged and incorrect use, the entire population can slowly develop resistance to antibiotics, ”said a doctor.
These self-medications can also be fatal in the elderly, pregnant women and children. “Most patients with Covid-19 only need symptomatic treatment. It’s a mild illness for most of the patients this time around. Don’t self-medicate with doxycycline, ivermectin, azithromycin, steroids, and molnupiravir, ”said Dr. Sivaranjani Santosh, Chief Pediatrician, Magna Center.
The doctor said the monoclonal antibodies (cocktail) might not even work against the Omicron variant. “It is especially important to see or examine the doctor / pediatrician often if symptoms are severe or if you are elderly or have co-morbidities or conditions with low immunity or if you have an infant / toddler at home. house, ”added Dr. Santosh. ]]>
South Dakota imposes new restrictions on medical abortions Sat, 08 Jan 2022 23:03:00 +0000 Current state law allows the medical abortion process to begin 72 hours “after the doctor has met the pregnant mother physically and personally”, except in a medical emergency, and usually only required an additional visit. in an approved establishment to receive the drugs necessary to treat it.

The rule means South Dakota will be the first state to require a visit to obtain misoprostol, according to Elizabeth Nash, state policy analyst at the Guttmacher Institute.

A medical abortion, also called a medical abortion, is a nonsurgical procedure that is effective until around 10 weeks of pregnancy. This involves taking mifepristone and misoprostol one or two days apart.

Usually, women are given both drugs at the same visit to their doctor or clinic. They take the mifepristone pill at the clinic and have to take the misoprostol pill at home a day or two later.

Under the new regulations, women in South Dakota will now have to go to an approved abortion center four times for a medical abortion.

The rule comes after the Biden administration temporarily relaxed federal medical abortion regulations in April, removing the requirement that mifepristone be dispensed in person during the Covid-19 pandemic.

The move prompted South Dakota and other conservative states to take action against the federal government.

South Dakota Gov. Kristi Noem, a Republican, signed an executive order in September ordering the state’s Department of Health to write rules to ensure that drugs distributed in the state cannot be mailed , among other restrictions.
In December, the FDA permanently lifted the requirement that the first drug be dispensed in person, allowing the pills to be mailed instead. The agency has also started requiring pharmacies that dispense the drug to be certified.

After a public hearing last month and a committee hearing that resumed Thursday, the Republican-majority Interim Rules Review Committee of the South Dakota Legislature voted to pass the rule requiring the in-person distribution of both drugs.

Current South Dakota law requires physicians to obtain “voluntary and informed written consent” from a pregnant woman for an abortion, except for medical emergencies.

Under the new rule, three days after a pregnant woman has given informed consent for a medical abortion, the woman can return to the clinic to receive the first drug, mifepristone. She is not allowed to take the drugs until nine weeks after conception.

But before dispensing the drug, according to the new regulations, a doctor must inform the woman that if she changes her mind and decides to carry the baby to term, it is possible to reverse the effects of mifepristone.

If she is taking this medication, she must wait 24 to 72 hours later and return to the clinic for a third time to have the second medication, misoprostol, delivered in person.

The abortion center staff should then schedule a follow-up appointment with the woman for 14 days after taking the drug.

The abortion facility should also monitor the patient and report to the Ministry of Health any complications requiring medical follow-up, what follow-up care was required, the facility where the follow-up appointment took place and whether the woman pregnant was sexually trafficked.

Ali Tornow, an attorney for the Department of Health, argued during Thursday’s hearing that “the purpose of this rule is to protect the health and safety of women in South Dakota by requiring the in-person delivery of both medications”.

Other supporters of the rule, including several doctors in South Dakota, have testified that cutting in-person visits could lead to life-threatening health complications for pregnant women.

North Central States of Planned Parenthood and the American Civil Liberties Union of South Dakota have criticized the new regulations, saying it mandates another “unnecessary” visit to the clinic.

Dr Sarah Traxler, chief medical officer of Planned Parenthood North Central States, said in Thursday’s hearing that the rule was “not medically necessary” and could instead prevent women “from taking the second drug, exposing them to thus at an increased risk “.

Traxler argued that for patients who spend hours driving to the clinic, additional travel is an “insurmountable barrier to care” and for some women, “the unpredictability of daily life can ultimately prevent patients to return to the clinic to receive the misoprostol. . “

Jett Jonelis, the South Dakota ACLU’s advocacy officer, said in a statement provided to CNN that warrants like South Dakota’s “represent dangerous political interference and compromise patient care and safety.”

“These restrictions violate patients’ rights to liberty, privacy and equal protection as guaranteed by the US Constitution by imposing significant burdens on access to abortion without proof of a valid medical justification.” , said Jonelis.

The American College of Obstetricians and Gynecologists (ACOG) and several other medical associations have advocated for the removal of federal restrictions on how drugs are administered.

The restrictions “do not make care safer, are not based on medical evidence or need, and create barriers to clinicians and patients’ access to medical abortion,” ACOG says on its website Web.

But “the limited available evidence suggests that using mifepristone alone without subsequent administration of misoprostol may be associated with an increased risk of bleeding,” the group said.

According to data collected by the FDA since the drug’s approval in 2000, of the 4.9 million women who took mifepristone for a medical abortion, 26 have died, a death rate of less than 0.0001%. .

The governor decides to make the new rule permanent

Noem “plans to work with the South Dakota legislature to make these and other protocols permanent,” his office said in a press release. The next session starts on Tuesday.

“I look forward to the day when the life of every unborn child is protected in South Dakota,” the governor said in a statement.

South Dakota has a number of restrictions on access to abortion, including a ban on abortion after 22 weeks of pregnancy, with a few exceptions.

It is also one of 19 states that require a doctor performing a medical abortion to be physically present during it, effectively prohibiting telemedicine from prescribing abortion medications, according to the Guttmacher Institute.

CNN’s Jen Christensen and Tierney Sneed contributed to this report.

Source link

Lupine launches antiviral drug Molnulup for COVID-19 treatment in India Fri, 07 Jan 2022 07:40:49 +0000 Molnupiravir has received emergency use authorization from DCGI for the treatment of adult patients with COVID-19 who are at high risk of disease progression, including hospitalization.

Representative image.PTI

New Delhi: Drugmaker Lupine announced Friday that it has launched an antiviral drug Molnupiravir under the brand name Molnulup in the country for the treatment of COVID-19.

Molnupiravir has received emergency use authorization from the Drug Controller General of India (DCGI) for the treatment of adult patients with COVID-19 who are at high risk of disease progression, including hospitalization.

“Molnulup’s approval is timely as India is once again experiencing an increase in the incidences of COVID-19. In the past two years since the emergence of COVID-19, there is a need for an oral antiviral drug that can be prescribed by healthcare professionals. and then taken by patients conveniently at home, ”Lupine – India Region Formulations (IRF) President – Rajeev Sibal said in a statement.

Thanks to the company’s strong distribution network, Molnulup would be readily available in Indian pharmacies to meet patient demand, he added.

Internationally, molnupiravir is an oral antiviral drug that has been approved by the UK Medicines and Health Products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) for the treatment of mild to moderate cases of COVID-19 in adults.

When administered orally, molnupiravir inhibits the replication of SARS-CoV-2, the causative agent of COVID-19.
Preclinical and clinical data have shown that Molnupiravir is effective against the most common variants of SARS-CoV-2, including the Gamma, Delta, and Mu variants.

Source link

Louisiana Medical Marijuana Patients Still Face Problems In The Workplace Wed, 05 Jan 2022 00:31:00 +0000

BATON ROUGE, Louisiana (WAFB) – The number of patients using medical marijuana is expected to increase rapidly now that the cost of the drug has been drastically reduced. However, enrolling in the program may put you in conflict with your employer.

Now that you can smoke your medical cannabis, you might feel like there is nothing else to worry about before you start. But you might want to think again. Most employers have a strict zero tolerance policy for drugs, including marijuana.

“This is a really complex issue, even in states that have fully legalized it has yet to be resolved,” said local lobbyist Peter Robins-Brown.

Peter Robins-Brown, with the Working for Louisiana Progress group, has studied this question closely.

“The big problem on the employer side, in particular, is that we don’t really have a good test for marijuana,” Robins-Brown said.

Drug tests used by companies can detect marijuana in a person’s system weeks ago, and in some cases even months. It is therefore almost impossible to detect whether someone is in a high position at work or not.

“So that makes it difficult for the people you need like drivers, commercial driver’s licenses, you use heavy machinery, so it’s like a workplace safety issue,” Robins-Brown continued.

Not knowing if you can take your medications while having a job can be an additional level of stress for patients.

“I don’t think people should be afraid of taking care of their mental health and then losing their jobs,” said Andie Andrews.

As a patient herself, Andrews said she knows firsthand the daily worries of using her medications.

“I know a lot of people who should have a medical card or who would benefit from having a medical card who probably drink a lot or use other things to heal themselves and they are terrified of being made redundant so they suffer,” Andrews said. .

If your job gives you a drug test and you’re positive even with a medical card, there can still be an uphill battle with your business unless it updates its policies with the latest law.

Experts said it was crucial for companies to move forward now and define their policy to avoid any future problems in this very gray area.

Click here to report a typo.

Copyright 2022 WAFB. All rights reserved.

Source link

Market Size Analysis of Smart Drug Adhesion Sensors in 2021 by Major Key Players Mon, 03 Jan 2022 06:41:00 +0000

New Jersey, United States, – Market Research Intellect has been analyzing the Smart Drug Adhesion Sensor technology and markets since 2018. Since then, through the analysis of the research of companies, we have been very close to the latest research and market developments.

In addition, Market Research Intellect works closely with many clients to help them better understand technology and the market environment and to develop innovation and commercialization strategies.

Market Research Intellect offers extensive expertise in the analysis of the Intelligent Drug Adherence Sensors market. We have been in this industry for 20 years and have closely followed the rise and / or fall, success and / or disappointment of many emerging technologies during this time.

This gives us a unique eye of experience when it comes to analyzing emerging technologies in electronic materials. This is very important as it helps to build a realistic market and technology roadmap that reflects the true potential of the technology based on its intrinsic characteristics and the true level of technology and business challenges it faces.

Get | Download a sample copy with table of contents, graphics and list of [email protected]

Further, the market revenue by region and country is provided in the Smart Drug Adhesion Sensors report. The report’s authors also shed light on common business tactics adopted by players. The major players in the global bSmart Drug Adherence Sensors Market and their complete profiles are included in the report. Additionally, investment opportunities, recommendations, and current trends in the global Smart Drug Adherence Sensors market are mapped by the report. As a result of this report, leading players in the Global Smart Drug Adhesion Sensors Market will be able to make right decisions, and plan their strategies accordingly, to stay ahead of the game.

The competitive landscape is an essential aspect that any key player should be aware of. The report highlights the competitive scenario of the Global Smart Medication Adherence Sensor Market to know the competition at national and global level. The market experts also provided an overview of each major player in the global Intelligent Drug Adhesion Sensor Market, taking into account key aspects such as business areas, production, and product portfolio. Further, the companies in the report are studied on the basis of key factors such as company size, market share, market growth, revenue, production volume, and profit.

The Major Players Covered By The Smart Drug Adherence Sensors Markets:

  • NGageIT digital health solutions
  • Schreiner MediPharm
  • HealthcarePrize Technologies
  • JoinTech
  • PillDrill
  • Johnson & johnson
  • Philips
  • McKesson

Smart Drug Adhesion Sensors Market Split by Type:

  • Hardware-centric smart drug adherence sensors
  • Software-centric smart drug adhesion sensors

Smart Drug Adhesion Sensors Market Split By Application:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

The Smart Drug Adhesion Sensor market report has been separated into distinct categories such as product type, application, end user, and region. Each segment is rated on the basis of CAGR, share and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Smart Drug Adhesion Sensors Market in the coming years. This segmental analysis will surely prove to be a useful tool for the readers, stakeholders and market players to get a complete picture of the Global Smart Medication Adherence Sensors Market and its growth potential in the coming years.

Get | Discount on purchasing this report @

Scope of the Smart Drug Adhesion Sensors Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
Covered segments Types, applications, end users, etc.
Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

The regional market analysis of Intelligent Drug Adherence Sensor can be depicted as follows:

Each regional smart drug adhesion sensor industry is carefully studied to understand its current and future growth scenarios. It helps the players to strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and to ensure you stay ahead of the competition.

Based on geography, the global smart drug adhesion sensor market has segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia-Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

Key questions answered in the report:

  • What is the growth potential of the Smart Medication Adherence Sensor markets?
  • Which product segment will take the lion’s share?
  • Which regional market will emerge as a precursor in the years to come?
  • Which application segment will grow at a sustained rate?
  • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
  • What are the major challenges that the global Smart Drug Adhesion Sensors markets may face in the future?
  • Who are the leading companies in the global smart drug adhesion sensor market?
  • What are the main trends that are positively impacting the growth of the market?
  • What are the growth strategies envisioned by the players to maintain their grip on the global Smart Medication Adherence Sensor market?

For more information or a query or a personalization before purchasing, visit @

Visualize the Smart Drug Adherence Sensors Market Using Verified Market Intelligence: –

Verified Market Intelligence is our BI platform for telling the story of this market. VMI provides in-depth predictive trends and accurate insight into over 20,000 emerging and niche markets to help you make key revenue impact decisions for a bright future. VMI provides a comprehensive overview and global competitive landscape by regions, countries and segments, as well as as key players in your market. Present your market reports and findings with built-in presentation capabilities, delivering over 70% of time and resources to investors, sales and marketing, R&D and product development. VMI supports data delivery in interactive Excel and PDF formats and provides over 15 key market indicators for your market.

Visualize the Smart Drug Adherence Sensors Market Using VMI @ https: //

The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Smart Medication Adherence Sensor market for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Smart Drug Adherence Sensor historical breakdown data from 2016 to 2020 and forecast to 2021-2029.

About Us: Market Research Intelligence

Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
United States: +1 (650) -781-480
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768

Website: –

Source link

Taking ibuprofen with naproxen may cause bleeding Sat, 01 Jan 2022 13:03:49 +0000

Compared to prescription drugs, over-the-counter (OTC) drugs tend to have fewer side effects. However, just because they are considered safe to consume does not mean that they can always be safely combined. Experts from the UK’s National Health Services (NHS) and the American College of Medical Toxicology (ACMT) say that in particular, there are two drugs that you should never take together. They warn that it could cause several different forms of bleeding, among other side effects. Read on to find out which over-the-counter medications should never be combined without a doctor’s go-ahead and what side effects you might experience if you do.

RELATED: Never Take These 2 Common Over The Counter Drugs At Once, Experts Warn.


Experts say that combining ibuprofen drugs like Advil or Motrin with naproxen drugs like Aleve can cause a serious side effect: bleeding. This is because all of these drugs are classified as nonsteroidal anti-inflammatory drugs (NSAIDs), which are commonly used to relieve pain, reduce inflammation, and lower temperature. These over-the-counter drugs work the same in the body, which means that taking more than one drug at the same time doubles the risk of side effects. These can “range from mild nausea to severe gastrointestinal bleeding”, Tim davis, PharmD, member of the National Community Pharmacists Association, recounts Prevention.

The NHS, which advises never to take naproxen with ibuprofen or other NSAIDs, says you may experience this bleeding in one of several forms. They say some patients have reported “vomiting blood or dark particles that look like coffee grounds”, as well as blood in their stool, which “could both be signs of bleeding and perforation of the stomach. or intestines “.

Additionally, you may notice blood in your urine as well as a decrease in the amount of urine you pass urine. This can be a sign of kidney damage, which can be a side effect of naproxen in extreme cases.

RELATED: If You Do This Common Thing With Your Pills, Get Your Liver Checked Now.

Close-up of elderly man suffering from stomach pain while having breakfast with his wife

According to the NHS, you may experience several side effects when taking naproxen, even on its own. Most often, it is confusion, headache, ringing in the ears, blurred vision, fatigue, dizziness, or rash. In more rare cases, you may also experience severe indigestion, stomach pain, frequent sore throat, nosebleeds, recurrent infections, signs of anemia, fever, slowed rhythm cardiac, etc.


The American College of Medical Toxicology echoes the NHS warning: “You cannot take multiple types of NSAIDs at the same time,” their experts warn. “You should choose which medicine to use and only use that medicine unless you switch completely to another. It is important to always read the labeling of over-the-counter medicines to avoid taking multiple NSAID-containing products at the same time. time, ”ACMT adds.

Davis suggests that if you must are taking two NSAIDs as your doctor tells you to, you should spread them out to minimize the risk of side effects. He says if your symptoms are not corrected by this strategy, you should speak with your doctor about any alternative medications that may be available to you.

For more health information sent straight to your inbox, sign up for our daily newsletter.

Woman talking to doctor

The ACMT notes that there are many over-the-counter and prescription drugs other than ibuprofen that are classified as NSAIDs, some of which are based on ibuprofen and others are based on naproxen. Although this list is not exhaustive, “the brand names of some of these drugs include Advil®, Bayer Select®, Dayquil Sinus®, Dimetapp Sinus®, Dristan Sinus®, Excedrin IB®, IBU®, Motrin®, Motrin IB, Nuprin®, Pamprin® and Aleve® ”, explains the organization.

Besides the increased risk associated with the combination of ibuprofen and naproxen – or two NSAIDs, for that matter – the NHS notes that there is also a risk of side effects when taking naproxen with aspirin, blood thinners, some steroids, water pills, antidepressants, some heart medications, and some medications used to treat rheumatoid arthritis.

Speak with your doctor if you’re at all concerned about your risk for a dangerous over-the-counter drug interactions involving any of these drugs.

RELATED: If You’re Over 60, Don’t Take This Over-The-Counter Drug Every Day, Officials Say.

Source link

Walmart and Sam’s Club to Distribute COVID-19 Drugs Through Federal Pharmacy Program Thu, 30 Dec 2021 21:44:14 +0000

BENTONVILLE, Ark. (KNWA / KFTA) – Walmart and Sam’s Club pharmacies stand ready to receive and dispense COVID-19 antiviral drugs approved by the United States Food and Drug Administration.

According to a press release from Walmart, retailers will begin handing out Paxlovid and Molnupiravir this week as stocks last.

The release says the drug will only be available at select Walmart and Sam’s Club stores in a limited number of states until more supply is available.

The drug is only available with a prescription from a health care provider. Customers and healthcare providers can go to and use the store locator to find the nearest store that offers the drug to send the electronic prescription.

Since the drugs are prescribed for people with COVID-19, they will only be available at Walmart and Sam’s Club by curbside pickup or drive-through drugstore windows, the statement said.

“We are committed to working with our state and federal partners to provide access to new treatment options such as licensed COVID-19 antiviral drugs, as they become available,” said Kevin Host, vice-president. senior president of pharmacy. “This drug offers clients the opportunity to recover at home and helps reduce the burden on our hospitals and communities. As we have been doing since the start of the pandemic, we are proud to support our communities with everyday essentials, healthy food, vaccines, medicines and other health care needs. health as we all work together to overcome the pandemic. “

Source link

Porch pirate steals essential drugs from Norfolk veteran Wed, 29 Dec 2021 04:28:26 +0000

NORFOLK, Virginia – Video from the doorbell shows a man running to the front porch of a Norfolk house and picking up several packages within seconds in broad daylight.

The cheeky theft was caught on Stephanie Allen’s doorbell camera a few weeks ago.

“Before I could even get out here to pick up the packages, someone had pulled up outside my house,” Allen said. “They stopped at a stop sign so as not to get caught. They got out of the car, walked up my driveway, grabbed my packages, almost fell and then ran away, and off they went.

Since then, Allen has said she is having a nightmare.

“As soon as I saw the video, I felt completely raped,” she said. “There is no reason to do this.”

The Navy veteran said his essential medication for his PTSD was in one of the stolen packages. She said the prescription helps her sleep at night.

“They help me control my dreams,” Allen said. “I fight at night. If I sleep without them, my service dog should lie on top of me to calm me down. It’s just a chore.

The theft also affected her vacation spirit. This year, she said she had not decorated.

“My husband and I didn’t really have Christmas because I’m usually the lady on the street who decorates the house for the block,” Allen said.

Allen said she had the drug delivered to her home through the VA. Collecting them from the hospital is not really an option for her. She said her husband had a compromised immune system.

“It’s like a Catch-22,” she said. “If I go, I submit to the possibility of getting sick and taking him home, or these porch pirates come back to my house and steal.”

To prevent porch hackers from stealing your packages, the experts have a few suggestions. Ship them to work; ask a neighbor who is at home to watch; notify others of the theft on social media or community apps like Nextdoor; require a signature for the package. You can also request other pickup and delivery options.

Allen immediately alerted his neighbors to Nextdoor, hoping that didn’t happen to anyone else.

“When people steal things, you don’t know what’s in those boxes or how people have to survive with what’s in those boxes,” Allen said. “There are people who depend on this drug. We need our medicine.

The VA sent another prescription for Allen and this time she said she would be on the lookout for when.

As for the thieves, she asks them to do the right thing and bring back her medication, no questions asked.

Source link